Blogs

“Patient-centeredness” is a facet of healthcare that suggests taking the power out of the hands of those who give care and into the hands of those who receive it. Yet, it is not only about surrendering to patients’ requests. Rather it is about teamwork and trust among the clinicians, patients, and patients’ families.

Physicians often rely on referrals for new patient flow through their practice. Unfortunately, most doctors network incorrectly, inconsistently and ineffectively.

The life science industry today has a significant opportunity at hand with the surge in data dependency. With the legislation of the 21st Century Cures Act, data has become the fuel for accelerating the drug development and innovation processes. The Cures Act defines the real-world evidence (RWE) as the clinical evidence about the usage and potential benefits or risks of a medical product derived from analysis of the real-world data (RWD). This facilitates an accurate view of the patient populations comprising larger socioeconomic, racial, age, and gender diversity, mostly un-represented by the RCTs.

Patient CRM is a critical criterion for maintaining long-term relationships while viewing patients as people and emanating a vibe of personal care. Patient CRM has an important impact on the evolving healthcare ecosystem, wherein- building upon ongoing patient relationships can result in prolonged customer loyalty, convalescent goodwill, and enhanced market credibility. The potential can be leveraged by delivering value over price. Combining information on patient demographics, social profiles, behavioral data, medical and appointment history from disparate sources into one complete data set is key to successful relationship management.

Command Center is a centralized approach to operations, where, real-time and predictive analytics from disparate data sources is aggregated and used as a coordinated approach to managing multiple stakeholders within a hospital or a health system.

The 21st Century Act was launched primarily for facilitating the acceleration of cancer research, and extending precision medicine to all diseases through the Precision Medicine Initiative (PMI). The Cures Act supports the US Food and Drug Administration (FDA) to streamline the process for drug and medical device approvals, promote increased use of electronic health records, and advance the implementation of telehealth services. The Cures Act facilitates advancing the medical product development and speedy delivery of medical innovations for patients in need.